Trials Starting With "R"

RAAVE: Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progressions of Aortic Stenosis

      -Trial Overview by Dr. Luis M. Moura et al (2007)

RABBIT II: Randomized Angioplasty Beta Blocker Intracoronary Trial II

      -Randomized Angioplasty Beta Blocker Intracoronary Trial II by Dr. Barry F. Uretsky (AHA 2006)

RACE: Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments Project

      -Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments (RACE) Project (AHA 2007)

      -A Systems Approach To Improve Survival of Patients with Myocardial Infarction In North Carolina Through Improved Application of Reperfusion Therapy by Dr. Christopher Granger

 

RAC-ER: Reperfusion of Acute Myocardial Infarction in Carolina Emergency Departments - Emergency Response Project

      -Overview by Dr. Christopher Granger (AHA 2010)

 

RADAR: A Randomized, Partially-Blinded, Multi-Center, Active-Controlled, Dose-Ranging Study Assessing the Safety, Efficacy, and Pharmacodynamics of the REG1 Anticoagulation System Compared to Unfractionated Heparin or Low Molecular Weight Heparin in Subjects with Acute Coronary Syndromes

      -Primary Results by Dr. Thomas Povsic (ACC 2011)

 

A Prospective RADAR Pharamacokinetic and Pharmacodynamic Substudy: Pegnivacogin (RB006), a Direct Factor IXa Inhibitor, Results in Consistent and Near Complete Inhibition of Factor IX Activity in Patients with Acute Coronary Syndromes

      -Study Overview by Dr. Thomas Povsic (AHA 2010)

Radiation Exposure

      -Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures by Dr. Brahmajee Nallamothu

 

Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis

      -Trial Overview by Dr. Enno Boudriot (CRT 2011)

Rapamycin- and Paclitaxel-Eluting Stents With Identical Biodegradable Polymeric Coating and Design Trial

      -Trial Overview by Dr. Rainer Wessley (ACC 2006)

 

RAPID GENE: A Prospective, Randomized Trial of Prasugrel vs. Clopidogrel in CYP2C19*2 Carriers Identified by Rapid Point-of-Care Genotyping

      -Trial Overview by Dr. Derek So (TCT 2011)

 

RAPID MI-ICE: Hypothermia in Awake STEMI Patients

      -Trial Results and Insights to CHILL MI by Dr. Goran Olivecrona (C3 Complex Intervention Meeting 2011)

 

RAPS: Radial Artery and Saphenous Vein Patency More than Five Years Following Coronary Artery Bypass Surgery

      -Trial Results by Dr. Stephen Fremes (ACC 2011)

 

Rate of Obstructive Coronary Disease in Elective Diagnostic Cath:

      -Overview by Dr. Manesh Patel

 

RAVEL: A RAndomised (double-blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™) in the treatment of patients with De Novo native coronary artery Lesions

      -A RAndomised (double-blind) study with the Sirolimus coated BX™ VElocity balloon expandable stent (CYPHER™) in the treatment of patients with De Novo native coronary artery Lesions by Dr. M. C. Morice

REACH: Reduction Of Atherothrombosis For Continued Health Registry

      -An International, Prospective Observational Study in Subjects at Risk of Atherothrombotic Events in an Outpatient Setting

REACT: Rescue Angioplasty Versus Conservative Therapy Or Repeat Thrombolysis Trial

      -Rescue Angioplasty versus Conservative Therapy or Repeat Thrombolysis Trial 6 month results by Dr. A. H. Gershlick (AHA 2004)

      -Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis of Randomized Trial by Dr. Harindra C. Wijeysundera

REALITY: Prospective, Randomized, Multicenter Head-to-Head Comparison of Cypher and Taxus Stent Systems

      -A Prospective, Randomized, Multi-Center Comparison Study of the CYPHER Sirolimus-Eluting and TAXUS Paclitaxel-Eluting Stent Systems by Dr. Marie-Claude Morice (ACC 2005)

      -8-Month Results by Dr. Marie-Claude Morice (ACC 2005)

 

Relation Between CYP2C19 Genotype and Platelet Function in Ticagrelor Versus Clopidogrel Treated Patients: Results from the ONSET/OFFSET and RESPOND Studies

      -Overview by Dr. Paul A. Gurbel

RELAx-AMI: Randomized Early versus Late Abciximab in Acute Myocardial Infarction treated with primary coronary intervention

      -Randomized Early versus Late Abciximab in Acute Myocardial Infarction treated with primary coronary intervention (RELAx-AMI Trial) by Dr. Mauro Maioli

 

RELY: Randomized Evaluation of Long-term anticoagulant therapY

      -Dabigatran Compared to Warfarin in 18,113 Patients with Atrial Fibrillation at Risk of Stroke

      -Efficacy and Safety of Dabigatran vs. Warfarin in Patients with Atrial Fibrillation: Japanese Population by Dr. Shinya Goto

 

RELY CHADS-VASC2 Subgroup: Randomized Evaluation of Long-term anticoagulant therapY

      -Insights to RELY Subgroup Analysis by Dr. Hisao Ogawa

 

REMEDEE: A Prospective, Randomized Trial of a Combination Bioabsorbable Polymer-Based Anti-CD34 Antibody Sirolimus-Eluting Stent vs. a Durable Polymer-Based Paclitaxel-Eluting Stent

      -Trial Overview by Dr. Michael Haude (TCT 2011)

 

REMEDIAL II: REnal Insufficiency Following Contrast MEDIA Administration TriaL

      -Trial Overview by Dr. Carlo Briguori (ACC 2011)

RENASICA-II: El Registro Nacional de los Síndromes Isquémicos Coronarios Agudos (National Registry of Acute Ischemic Coronary Syndromes in Mexico)

      -Right Bundle Branch Block as Risk Marker of In Hospital Mortality in ST-Elevation Acute Myocardial Infarction. A RENASICA-II Substudy by Dr. Ursulo Juarez (ESC 2007)

REPLACE-2: Randomized Evaluation Of PCI Linking Angiomax To Reduced Clinical Events

      -Elderly Patients with Major Bleeding or Need for Transfusion Complicating Percutaneous Coronary Intervention Have an Increased Risk of 30-Day and 1-Year Mortality by Dr. Michael A. Nelson (AHA 2006)

      -Eptifibatide plus Heparin Increases the Risk of Major and Minor Hemorrhagic Complications Compared to Bivalirudin in Patients with Normal Renal Function Undergoing Percutaneous Coronary Intervention by Dr. Michael C. McDaniel (AHA 2006)

RESET: A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation

      -Trial Overview by Dr. Myeong-Ki Hong (TCT 2012)

RESET GENE: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose Versus Prasugrel.

      -Study Overview by Dr. Gennaro Sardella (ACC 2012)

RESPECT: Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment

      -Final Results with Primary End Point Analyses by Dr. John D. Carroll (TCT 2012)

 

RESPONSE: Randomized Evaluation of Secondary Prevention by Outpatient Nurse Specialists

      -Trial Results by Dr. Ron JG Peters (ESC 2010)

 

RethinQ: The Resynchronization Therapy in Normal QRS Study

      -The Resynchronization Therapy in Normal QRS (RethinQ) Study by Dr. John F. Beshai (AHA 2007)

Revascularization vs Med Rx

      -The Impact of Revascularization on Mortality in Patients with Non-Acute Coronary Artery Disease by Dr. Allen Jeremias

REVERSAL: Reversing Atherosclerosis with Aggressive Lipid Lowering

      -Reversing Atherosclerosis with Aggressive Lipid Lowering by Dr. Steven E. Nissen (AHA 2003)

REVERSE: REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction

      -REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction: Results of the REVERSE Trial

 

REVERSE STEMI: Interventionalist Versus Patient Transfer Strategies for Primary Percutaneous Coronary Intervention in Patients with Acute ST-Eevation Myocardial Infarction

      -One Year Trial Results by Dr. Wei Feng Shen

 

RIFLE STEACS: A Prospective, Randomized Trial of Radial vs. Femoral Vascular Access in Patients with ST-Segment Elevation Myocardial Infarction

      -Trial Overview by Dr. Enrico Romagnoli (TCT 2011)

 

RIO: Rimonabant In Overweight/Obesity

      -Rimonabant: A new approach to multiple cardiometabolic risk factors

RIO EUROPE: A Randomised Double-Blind Study of Weight Reducing Effect and Safety of Rimonabant in Obese Patients with or without Comorbidities

      -A Randomised Double-Blind Study of Weight Reducing Effect and Safety of Rimonabant in Obese Patients with or without Comorbidities by Dr. Luc Van Gaal (ACC 2005)

RIO LIPIDS: Rimonabant in Obesity

      -Rimonabant in Obesity by Dr. Jean-Pierre Despres (ACC 2004)

 

RIVAL: A Randomized Comparison of Radial versus Femoral Access for Coronary Angiography or Intervention in Patients with Acute Coronary Syndromes

      -Trial Results by Dr. Sanjit Jolly (ACC 2011)

 

ROCKET-AF: Stroke Prevention Using the Oral Direct Factor Xa Inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation

   -Trial Overview by Dr. Kenneth Mahaffey and Dr. Keith Fox (AHA 2010)

 

ROMA: A Prospective Randomized Trial of Rosuvastatin Pretreatment Prior to Percutaneous Coronary Intervention

   -A Prospective Randomized Trial of Rosuvastatin Pretreatment Prior to Percutaneous Coronary Intervention By: Dr. Gennaro Sardella (TCT 2010)

 

ROMA II Reload: Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis

   -Trial Overview By: Dr. Gennaro Sardella (TCT 2011)

 

ROMICAT II: Multicenter Randomized Comparative Effectiveness Trial of Cardiac CT vs Alternative Triage Strategies in Acute Chest Pain Patients in the Emergency Department

   -Trial Results by Dr. Udo Hoffmann (ACC 2012)

 

ROTAXUS: A Prospective, Randomized Trial of High-Speed Rotational Atherectomy Prior to Paclitaxel-Eluting Stent Implantation in Complex Calcified Coronary Artery Lesions

  -Trial Overview by Dr. Gert Richardt (TCT 2011)

 

RUTH: Raloxifene Use For The Heart

      -Antiplatelet Therapy Use and the Risk of Venous Thromboembolic Events in the Double-Blind Raloxifene Use for the Heart (RUTH) Trial by Dr. C. Duvernoy (AHA 2007)

 

RUTHERFORD: Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder

      -Interim Results by Dr. Frederick J. Raal (AHA 2012)

 

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs test

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster